Introduction to *Paenibacillus* {#Sec1}
===============================

Bacteria belonging to the genus *Paenibacillus* have been isolated from a variety of environments, with many of the species being relevant to humans, animals, plants, and the environment. The majority of them are found in soil, often associated with plants roots: these rhizobacteria promote plant growth and can be exploited for use in agriculture. Many species of *Paenibacillus* produce antimicrobial compounds that are useful in medicine or as pesticides, and many yield enzymes that could be utilized for bioremediation or to produce valuable chemicals. Some species are pathogens to honeybees or other invertebrates; while others are occasional opportunistic infectors of humans. In fact, many of these pertinent characteristics overlap within the same species. In accordance with their diverse characteristics, members of *Paenibacillus* have been discovered in disparate habitats, from polar regions to the tropics, and from aquatic environments to the driest of deserts (Additional file [1](#MOESM1){ref-type="media"}).

Species of *Paenibacillus* were originally included in the genus *Bacillus*, which historically was defined based on morphological characteristics in common with the type species *Bacillus subtilis*, isolated in 1872. Any bacterium was classified as *Bacillus* if it was rod-shaped, aerobic or facultatively anaerobic, and could form endospores allowing it to remain dormant in inhospitable conditions. However, these characteristics are actually very ancient and not suitable for grouping species into a single genus \[[@CR1]\]. A study in 1988 using numerical taxonomy based on 188 unit characters suggested a framework for splitting *Bacillus* into several genera \[[@CR2]\]. A more accurate representation of phylogenetic relationships among these bacteria was attained in 1991, when 16S rRNA gene sequences were determined for standard strains of 51 species then defined as *Bacillus* \[[@CR2], [@CR3]\]. Phylogenetic analyses showed that these sequences segregated into at least five distinct clusters, one of which was reassigned to the novel genus *Paenibacillus* in 1993 \[[@CR4]\] and includes the type species *Paenibacillus polymyxa* \[[@CR5]\]. The name *Paenibacillus* is derived from the Latin adverb *paene*, meaning almost; almost a *Bacillus* \[[@CR4]\].

Not long after the creation of the genus, organisms previously thought of as separate *Paenibacillus* species were re-classified as equaivalent: for example, *Paenibacillus gordonae* was determined to be a synonym of *Paenibacillus validus*, and *Paenibacillus pulvifaciens* was determined to be a subspecies and later a synonym for *Paenibacillus larvae* \[[@CR6], [@CR7]\]. Several species were also reclassified into the genus *Paenibacillus*, including *Clostridium durum*, *Bacillus alginolyticus*, *Bacillus chondroitinus*, *Bacillus curdlanolyticus*, *Bacillus glucanolyticus*, *Bacillus kobensis*, and *Bacillus thiaminolyticus* \[[@CR8], [@CR9]\]. In 1997, a proposed emendation described *Paenibacillus* as having 16S rDNA sequences with more than 89.6% similarity, being motile by means of peritrichous flagella (projecting in all directions), and being non-pigmented on nutrient agar, among other characteristics. Species of this genus can be gram positive, gram negative, or gram variable, in addition to sharing the basal characteristics ascribed to *Bacillus* \[[@CR8]\].

The number of useful or otherwise relevant *Paenibacillus* species has spawned genome sequencing of 212 strains representing 82 species, as well as 79 uncharacterized strains (Additional file [2](#MOESM2){ref-type="media"}), and a variety of patents (Table [1](#Tab1){ref-type="table"}). Genome size ranges from 3.02 Mbp (for *P. darwinianus* Br, isolated from Antarctic soil \[[@CR10]\]) to 8.82 Mbp (for *P. mucilaginosus* K02, implicated in silicate mineral weathering \[[@CR11]\]) and genes number from 3064 (*P. darwinianus* Br) to 8478 (*P. sophorae* S27, a rhizobacterium). Like *P. darwinianus*, the insect pathogens *P. larvae* and *P. popilliae* have genomes on the smaller side (4.51 and 3.83 Mbp, respectively), perhaps reflecting their niche specialization. The DNA G + C content of *Paenibacillus* ranges from 39 to 59 mol% \[[@CR12]\].Table 1Selection of active patentsPatent numberPatenting countryPatenting agencyPatent titleIssue dateUS9017692B2United StatesOhio State Innovation FoundationAntimicrobial agent, bacterial strain, biosynthesis, and methods of use28-Apr-15US8822179B2United StatesUniversity of Florida Research Foundation, Inc.Nucleic acid compositions and the encoding proteins21-Feb-12US8652819B2United StatesUniversity of Georgia Research Foundation, Inc.*Paenibacillus* spp. and methods for fermentation of lignocellulosic materials18-Feb-14US8329430B2United StatesKorea Research Institute of Bioscience and BiotechnologyPolymyxin synthetase and gene cluster thereof11-Dec-12US8084418B2United StatesDow AgroSciences LLCMethods of inhibiting insects by treatment with a complex comprising a *Photorhabdus* insecticidal protein and one or two Xenorhabdus enhancer proteins27-Dec-11US7935335B2United StatesKaken Pharmaceutical Co., Ltd.Strains belonging to the genus *Paenibacillus* and method of controlling plant disease by using these strains or culture thereof03-May-11CN104255816AChinaQingdao Jinxiu Shuiyuan Commerce And Trade Co LtdNon-polluted antibacterial peptide biopesticide07-Jan-15KR1020140115022KoreaMOS Co., LtdNovel *Paenibacillus* peoriae gsoil 1119 having an excellent antifungal effect against plant pathological fungi, and microorganism preparation for controlling containing same30-Sep-14WO2014146881A1InternationalWacker Chemie AGMicroorganism strain and method for the fermentative production Of C4 compounds from C5 sugars27-Feb-14CN201410255003ChinaStanley Fertilizer Stock Co., Ltd.Special functional biological slow-release fertilizer for chilies13-Aug-14CN201410181469ChinaShandong UniversityMixed flora microbial preparation and application thereof in sewage treatment16-Jul-14KR1020130055820KoreaEcodream Farm Service Corporation*Paenibacillus* Kribbesis T9 having clubroot control effect for cabbage04-Jul-14WO2014099525A1InternationalDanisco US Inc*Paenibacillus* curdlanolyticus amylase, and methods of use, thereof26-Jun-14CN201210538699ChinaHenan Academy Of Agricultural SciencesBio-control bacterium for preventing and treating sesame wilt disease, separation method, inoculant, and application of the inoculant18-Jun-14CN201410006084ChinaNortheastern UniversityMethod for removing heavy metal ions in water by using fermentation broth of bacterium producing flocculant04-Jun-14CN201410018001ChinaYancheng Institute Of TechnologyGene engineering bacteria for producing ultrahigh-optical purity R,R-2,3-butanediol as well as construction method and application thereof30-Apr-14CN201310579323ChinaTianjin Wuqing District Plant Protection StationBiological straw decomposition agent and preparation method thereof05-Mar-14KR1020120076529KoreaKorea Research Institute Of Bioscience And BiotechnologyMethod for increasing potato production using novel *Paenibacillus* Sp.22-Jan-14KR1020120064809KoreaGeon-Nong Co., Ltd.Deodorant for decreasing bad smell of septic tank, garbage dump, sewerage, and compost producing apparatus using complex microbial agent27-Dec-13KR1020120022400KoreaMoon, Byung Woo Yeongam Fig Cluster AgencyNutrient solution composition for box culturing ficus carica capable of easily adjusting electrical conductivity (ec) and ph according to the amount of the nutrient composition and using method thereof13-Sep-13CN201210212246ChinaTaicang Zhoushi Chemical Product Co., Ltd.Method for producing ethanol by adopting mixed culture organism by means of glycerol fermentation03-Oct-12KR1020100133442KoreaKonkuk University Industrial Cooperation Corp.Novel strain *Paenibacillus* xylanexedens Sk2925 With excellent activity of decomposing xylan03-Jul-12JP2009004013JapanYan; Sun ChanWastewater treatment method22-Jul-10JP2004059241JapanKubota CorpMethod for cleaning contamination caused by polychlorinated biphenyls/polycyclic aromatic hydrocarbons15-Sep-05EP1490468GermanyAladin Gesellscaft für Innovative mikrobiologische Systeme GmbHBiological pipe cleaner29-Dec-04DE19706598A1GermanyKnoell Hans Forschung EV Univ Schiller JenaMacrolide antibiotic apidiothricin27-Aug-98WO2016020371A1GermanyBASF SEAntifungal *Paenibacillus* strains, fusaricidin-type compounds, and their use11-Feb-16WO2016019480A1ChileUniversidad de Santiago de Chile*Paenibacillus* polymyxa SCHC 33 bacterial strain, and use thereof to combat phytopathogenic fungi in fruits, vegetables, or plants11-Feb-16WO2016019480A1United StatesDanisco US Inc.*Paenibacillus* and *bacillus* spp. mannanases17-Mar-16EP2871073A1GermanyRoche Diagnostics GmbhRecombinantly produced neutral protease originating from *Paenibacillus polymyxa*16-Jan-14WO2015153956A1United StatesThe Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada, Las Vegas*Paenibacillus larvae* treatment with phage lysin for American Foulbrood Disease08-Aug-15WO2015092548A3DenmarkDupont Nutrition Biosciences Aps*Paenibacillus* strains and compositions thereof that inhibit microorganisms17-Sep-15WO2015101116A1ChinaBright Dairy & Food Co., LTDNew *Paenibacillus* sp. strain, as well as culture method and use thereof07-Jul-15US9085789B2United StatesUniversity of Georgia Research Foundation Inc.*Paenibacillus* spp. and methods for fermentation of lignocellulosic materials18-Feb-2014EP2999801A1United StatesBiowish Technologies, Inc.Microbial-based waste water treatment compositions and methods of use thereof30-Mar-2016EP2999340A1JapanHisataka GodaDrug-resistant microbe and variant microbe disinfectant containing chlorous acid aqueous solution30-Mar-2016WO2016054176A1United StatesDanisco US Inc.Compositions comprising beta-mannanase and methods of use07-Apr-2016US8956842B2KoreaKorea Research Institute of Chemical Technology*Paenibacillus* sp. HPL-3 strain producing xylanase having heat-resistance, a wide range of optimum pH and high activity, a novel xylanase separated from the strain, and a method for mass-production of the same using the transformant originated from the strain17-Feb-2015EP2929022A1United StatesDanisco US Inc.Compositions and methods of use14-Oct-2015EP2759600A4JapanHayashibara CoProduction method for powder containing crystalline, -trehalose dehydrate08-Jul-2015EP2556835A1JapanJapan Eco-Science Co. Ltd.Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism13-Feb-2013WO2015114552A1South AfricaUniversity of PretoriaPlant growth promoting rhizobacterial strains and their uses06-Aug-2015WO2015123752A1CanadaGreen On Industries, Inc.Composition and method for hydrocarbon and lipid degradation and dispersal27-Aug-2015WO2015109766A1ChinaBright Dairy & Food Co., Ltd.Method for preparing fermentation broth extracts having chymosin activity and products thereof30-Jul-2015WO2015113175A1ChileUniversidad Del DesarrolloBiocide composition for controlling pests affecting European honey bees, comprising a water-soluble *Olea europaea* extract06-Aug-2015WO2015023662A1United StatesBio-Cat Microbials LlcCompositions comprising bacillus strains and methods of use to suppress the activities and growth of fungal plant pathogens19-Feb-2015US9187381B1United StatesBio AG Corp.Composition and method for formulating a biofertilizer and biopesticide17-Nov-2015US9113605B2United StatesCore Intellectual Properties Holdings, LlcMethods and compositions to aggregate algae25-Aug-2015Patents were searched at the World Intellectual Property Organization (WIPO), European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and Japan Patent Office (JPO)

Currently, *Paenibacillus* is one of eight genera included in the family Paenibacillaceae. However, a phylogram of the family suggests that *Paenibacillus* is paraphyletic, with the other genera (*Aneurinibacillus*, *Brevibacillus*, *Cohnella*, *Fontibacillus*, *Oxalophagus*, *Saccharibacillus*, and *Thermobacillus*) forming subsidiary clades. The genus *Paenibacillus* is therefore expected to undergo significant taxonomic subdivision in the future \[[@CR1]\]. Conversely, the number of novel species being identified as *Paenibacillus*, and established species being reclassified as such, continues to grow, and the genus currently comprises around 200 species (Additional file [1](#MOESM1){ref-type="media"}). Despite this complexity, the present review attempts to summarize all members currently classified as *Paenibacillus* with respect to the characteristics---both positive and negative---that are most relevant to humankind.

Plant growth promotion {#Sec2}
======================

The genus *Paenibacillus* contains many species which are known to promote the growth of plants including maize \[[@CR13]\], *Populus* \[[@CR14]\], pumpkin \[[@CR15]\], rice \[[@CR16]\], switchgrass \[[@CR17]\], and many others. Like other plant growth-promoting bacteria, they accomplish this through various facets. Plant-associated species of *Paenibacillus* can directly influence plant growth by producing indole-3-acetic acid (IAA) and other auxin phytohormones, solubilizing inaccessible phosphorous into form that can be taken up by plant roots, and some species can also fix atmospheric nitrogen \[[@CR18]\]. In addition, *Paenibacillus* helps to control phytopathogens by triggering induced systemic resistance (ISR) and/or producing a variety of biocidal substances (see "[Biocontrol](#Sec7){ref-type="sec"}" and "[Antimicrobial peptides](#Sec11){ref-type="sec"}" sections).

While some plant growth promoting bacteria, including *P. macerans*, are used in commercial biofertilizers, their use is currently limited. The establishment and performance of these microorganisms in the field can be affected by numerous environmental variables, such as soil pH, salinity, moisture content, and temperature \[[@CR19]\]. Despite these limitations, continuing research may enable more widespread use of these biofertilizers. One benefit of inoculating fields with endospore-forming bacteria such as *Paenibacillus* is their capacity to survive for long periods in the soil under adverse environmental conditions \[[@CR20]\].

Nitrogen fixation {#Sec3}
-----------------

Atmospheric nitrogen (N~2~) is relatively inert, and must be fixed to a usable chemical form before being incorporated into amino acids, nucleotides, and other metabolites. As eukaryotes do not have the ability to fix their own nitrogen, its bioavailability in the soil is a major limiting factor for plant growth, and farmers routinely apply nitrogen fertilizers to ensure crop productivity. Commercial nitrogen fertilizers are produced by the Haber-Bosch process through reducing nitrogen gas, which uses fossil fuels for the energy needed, and the resulting carbon dioxide emissions and pollution contributing to global warming and adverse effects on human health. Additionally, over 50% of synthetic nitrogen fertilizer is not taken up by crops, and is instead lost to the environment where it contributes to eutrophication, greenhouse gas production, and acid rain \[[@CR21]\]. Such nitrogen pollution is considered to be the second most important driver of anthropogenically induced global change, next to the perturbation of the carbon cycle \[[@CR22]\]. However, its effects can be lessened by inoculating fields or crops with microorganisms, including some strains of *Paenibacillus*, that fix nitrogen in or around plant roots, where it is actually needed.

Nitrogen-fixing (diazotrophic) bacteria and archaea primarily use a molybdenum (Mo)-dependent nitrogenase (Nif) to catalyze the reduction of N~2~ to bioavailable NH~3~. Synthesis of this enzyme requires a minimum of three structural genes and three genes for FeMo-cofactor biosynthesis \[[@CR23]\]. However, optimum activity requires the presence of additional genes, as the specific activity of a nitrogenase expressed in *Escherichia coli* was only about 10% of that observed in the *Paenibacillus* species from which it was derived; and improvements were made with additional transgenes \[[@CR24]\]. Alternatives to Nif have active site cofactors that lack Mo, instead containing both vanadium and iron (Vnf), or iron only (Anf) \[[@CR23]\].

More than 20 *Paenibacillus* species can fix nitrogen \[[@CR25]\], with single species comprising both diazotrophic and non-diazotrophic strains \[[@CR26], [@CR27]\]. The *nif* gene cluster is highly conserved among nitrogen-fixing *Paenibacillus*, with most clusters containing 9 genes within 10.5--12 kb, and exhibiting over 80% identity \[[@CR25]\]. Most of the Nifs appear monophyletic, having likely been derived from a single horizontal gene transfer, followed by duplications and gene cluster loss in some lineages \[[@CR27], [@CR28]\]. At least two strains, *P. riograndensis* SBR5^T^ and *P. durus* DSMZ1735, have additional *nif*s from a potentially independent, more recent horizontal transfer, although these genes may not be functional \[[@CR28]\]. The alternative nitogenase Vnf is encoded in the genomes of *P. zanthoxyli* JH29 and *P. azotofixans* ATCC 35681, while Anf is encoded by *P. sophorae* S27, *P. forsythia* T98 \[[@CR25]\], and *P. riograndensis* SBR5^T^; all of which also contain the *nif* cluster. Having Vnf or Anf, in addition to Nif, may provide an selective advantage in certain circumstances, as *anf* shows higher expression under molybdenum-depleted conditions \[[@CR28]\].

The ability of organisms to fix nitrogen can be identified by growth on nitrogen-free medium, while reliable estimates of nitrogenase activity can be obtained using ^15^N~2~ fixing assays. However, acetylene reduction assays are less costly than ^15^N~2~ and are sufficient to estimate relative nitrogenase activities. These assays are based on the ability of nitrogenases to also reduce acetylene (C~2~H~2~) to ethylene (C~2~H~4~). Such assays have found a wide range of relative activities among nitrogen-fixing *Paenibacillus* species, for example, with *P. zanthoxyli* DSM 18202 producing 140 times more activity than *P. peoriae* DSM 8320 \[[@CR29]\].

Phosphate solubilization {#Sec4}
------------------------

Next to nitrogen, phosphorus is the second most important element limiting plant growth and productivity. Although it is abundant in soils, only 0.1% exists in a soluble form that can be taken up by plant roots; the remainder forms insoluble mineral complexes, or is immobilized in organic matter. Chemical phosphorus fertilizers are therefore used to supplement soluble phosphorus on most agricultural soils, but these are costly and adversely impact the environment \[[@CR19]\].

Unlike nitrogen, phosphorus fertilizer is a finite resource obtained from rock phosphate, and once high-quality deposits are used, the shift to lower grade rock will result in even higher costs. The manufacturing process emits poisonous hydrogen fluoride gas. Once applied to the field, less than 30% of the chemical fertilizer is typically used by the plant, with much of the rest incorporating into inorganic mineral complexes within the soil. The rise in insoluble phosphorus can disturb microbial diversity, eventually leading to reduced soil fertility; and trace amounts of heavy metal impurities in the fertilizer can accumulate over time. Eutrophication can also result as phosphorus-rich soil erodes into aquatic systems \[[@CR19]\].

As is the case for nitrogen, the application of chemical phosphorus fertilizer could be reduced by inoculating fields with phosphorus-solubilizing microorganisms, such as *Paenibacillus*. While bacteria may have drawbacks when compared to phosphorus solubilizing fungi, such as lower activity and a tendency to lose activity after repeated sub-culturing \[[@CR19]\], some may nonetheless become preferred bio fertilizers due to additional qualities that simultaneously benefit plant growth.

Phosphorus solubilizing microorganisms use a variety of mechanisms that make phosphorus available to plants, with the principal method being organic acid (especially gluconic acid) production. Such acids can directly dissolve mineral phosphorus through anion exchange, chelate metal ions, or lower soil pH to release phosphorus from the mineral complex. Microorganisms also release phosphorus from their substrates during enzymatic degradation, and from their own cells upon death \[[@CR19]\].

Genomic analyses suggest that most *Paenibacillus* strains can solubilize phosphorus through gluconic acid production: a study of 35 strains comprising at least 18 species found that all but two strains have genes involved in gluconic acid production, encoding glucose-1-dehydrogenase and gluconic acid dehydrogenase. The strains apparently lacking these genes were *P. beijingensis* 1--18 and *P. terrae* HPL-003; while those having the genes included strains from *P. azotofixans*, *P. curdlanolyticus*, *P. dendritiformis*, *P. elgii*, *P. forsythia*, *P. graminis*, *P. lactis*, *P. massiliensis*, *P. mucilaginosus*, *P. peoriae*, *P. polymyxa*, *P. sabinae*, *P. sonchi*, *P. sophorae*, *P. vortex*, and *P. zanthoxyli* \[[@CR27]\]. Genes for the uptake and degradation of phosphonates, which containing the highly stable C-P bond, and for a phosphate-specific transport system, were found in all analysed genomes \[[@CR27]\]. Phosphorus solubilisation has been confirmed by *P. elgii* \[[@CR30]\], *P. kribbensis* \[[@CR31]\], *P. macerans* \[[@CR32]\], *P. mucilaginosus* \[[@CR33]\], *P. polymyxa* \[[@CR32]\], *P. xylanilyticus* \[[@CR34]\], and several unclassified strains.

Iron acquisition {#Sec5}
----------------

Like phosphorus, iron is abundant in soil in mainly in non-bioavailable form. Particularly in alkaline or chalky soils, it forms largely insoluble Fe^3+^ oxy-hydroxides, which are not readily used by either microorganisms or plants. Most microorganisms therefore reduce Fe^3+^ to Fe^2+^ using ferrireductases or solubilize it with extracellular, low molecular weight Fe^3+^ chelators called siderophores \[[@CR35]\], which are released under iron limited conditions. The soluble Fe^3+^-siderophore complexes are available to plants as well as microorganisms \[[@CR36]\], being recognized by specific membrane receptors and transported into cells \[[@CR37]\].

Siderophores are synthesized mainly by nonribosomal peptide synthetases (NRPSs), which are encoded by gene clusters. These multienzyme complexes consist of various modules that each incorporate one or more specific amino acids into a peptide backbone (see also "[Nonribosomal lipopeptides](#Sec13){ref-type="sec"}" section). The three types of siderophores are classified based on their functional groups, being catecholates, hydroxamates, and α-hydroxy carbolates \[[@CR38]\]. However, few siderophores have thus far been characterized from *Paenibacillus*.

*Paenibacillus larvae* produces a catecholate -type siderophore called bacillibactin, which is also made by *Bacillus subtilis* and members of the *Bacillus cereus* sensu lato group \[[@CR38]\]. Bacillibactin is a cyclic trimeric lactone of 2,3-dihydroxybenzoate (DHB)-glycine-threonine. Similar to bacillibactin, paenibactin is a cyclic trimeric lactone of 2,3-DHB-alanine-threonine produced by *P. elgii* B69, the difference being the amino acid inserted between the DHB and threonine units \[[@CR37]\]. Catecholates have not been detected in cultures of *P. polymyxa* SQR-21, which instead produces hydroxamate-type siderophores at low concentrations in the late log phase \[[@CR35]\]. Siderophore synthesis gene clusters are present only in some strains of some *Paenibacillus* species, and are thought to have been obtained from fairly recent events of horizontal gene transfer \[[@CR26], [@CR37]\].

Aside from siderophore production, *Paenibacillus* may promote iron uptake by plants via other mechanisms. *P. polymyxa* BFKC01 transcriptionally activates plant genes involved in iron deficiency responses, including the membrane bound ferric chelate reductase *fro2* and the divalent metal transporter *irt1*, as well as genes involved in the synthesis of iron-mobilizing phenolic compounds \[[@CR39]\]. *Paenibacillus*-produced organic acids, such as oxalic acid, could also conceivably contribute to iron uptake, but release of such acids does not appear to be iron regulated \[[@CR35]\].

Phytohormone production {#Sec6}
-----------------------

Auxins are hormones that are crucial regulators of gene expression and development throughout a plant's life, participating in cell division, elongation, fruit development and senescence. There are multiple classes of auxins, but the first identified and most abundant in nature is indole-3-acetic acid (IAA) \[[@CR40]\]. Although plants are able to produce their own phytohormones, they can also utilize foreign sources produced by other organisms.

In addition to plants, IAA is synthesized by fungi and bacteria, including *Paenibacillus* and most other plant-associated bacteria \[[@CR20]\]. The production of IAA by *Paenibacillus* is thought to contribute to plant growth promotion \[[@CR41]\]. However, this hormone has a complex relationship with plants, being produced by both plant-growth-promoting and phytopathogenic bacteria. Lower levels of exogenous IAA typically increase plant growth and productivity, while high levels lead to disease susceptibility \[[@CR20]\]. Perhaps auspiciously, the tryptophan precursor of IAA is energetically costly, and considerable amounts are only made with an excess of tryptophan, which may be exuded from the plant, typically during the stationary phase of bacterial growth \[[@CR41]\].

Three different enzymatic pathways have been identified that convert tryptophan to IAA; in bacteria, the most common is the indole-3-pyruvic acid pathway, which is also present in plants. In this pathway, an aminotransferase deaminates tryptophan to yield indole-3-pyruvic acid, which is then converted to indole-3-acetaldehyde by a decarboxylase in the rate-limiting step. Finally, indole-3-acetaldehyde is oxidized to IAA via an unknown enzyme \[[@CR20], [@CR41]\].

Genes encoding putative indolepyruvate decarboxylase (IpdC), a key enzyme in the indole-3-pyruvic acid pathway, are present in all analyzed *Paenibacillus* genomes, with over 96% amino acid identity between strains across 98% of the sequence \[[@CR27]\]. IpdC belongs to a family of enzymes that exhibit some level of substrate promiscuity, and substitution of only a few amino acids in the active site can shift the primary affinity to another substrate. The active site must therefore be analysed in detail to confirm a gene's identity as an *ipdC* homologue whose primary function is IAA synthesis \[[@CR41]\]. However, the *Paenibacillus* genomic analysis did not identify genes involved in the other IAA pathways, that is, tryptophan monooxygenase or indole-3-acetamide hydrolase, suggesting that this genus most likely relies on the indole-3-pyruvic acid pathway \[[@CR27]\].

Biocontrol {#Sec7}
==========

Perhaps the most notable plant-growth promoting feature of *Paenibacillus* species comes from their numerous biocontrol capabilities. By inducing the plant's own resistance mechanisms or by producing biocidal substances, *Paenibacillus* can neutralize a diverse variety of phytopathogens and insect herbivores. *P. polymyxa* alone has been shown to provide protection to cauliflower \[[@CR42]\], pea \[[@CR43]\], ginseng \[[@CR44]\], cucumber \[[@CR45]\], chickpea \[[@CR46]\], peanut \[[@CR47]\], soybean \[[@CR48]\], pepper \[[@CR49]\], and more. Other species of *Paenibacillus* that have biocontrol properties include *P. alvei* \[[@CR50]\], *P. brasilensis* \[[@CR51]\], *P. dendritiformis* \[[@CR52]\], *P. ehimensis* \[[@CR53]\], *P. elgii* \[[@CR54]\], *P. kobensis* \[[@CR55]\], *P. lentimorbus* \[[@CR56]\], *P. macerans* \[[@CR57]\], *P. peoriae* \[[@CR58]\], and *P. thiaminolyticus* \[[@CR59]\].

Tolerance of some *Paenibacillus* species to commercial fungicides and insecticides \[[@CR60]\] indicates the possibility of using these microorganisms in combination with existing control solutions. However, when considering *Paenibacillus* or its compounds for biocontrol, it is important to note that competition can occur both ways. For example, while low levels of fusaric acid, a toxin produced by the fungus *Fusarium oxysporum*, increase production of the antifungal enzyme β-1,3-glucanase by *P. polymyxa* strains WR-2 and SQR-21, higher levels of fusaric acid actually decrease their production and result in reduced *P. polymyxa* growth \[[@CR61]\]. Furthermore, *Paenibacillus* may compete with other beneficial organisms \[[@CR62], [@CR63]\].

Induced systemic resistance {#Sec8}
---------------------------

Many beneficial rhizobacteria and root-associated mutualists, including members of *Paenibacillus*, can trigger induced systemic resistance (ISR) when present in high enough population densities. ISR is a latent defense mechanism occurring in plant tissues that are spatially separated from the inducer, providing enhanced protection against a range of pathogens or pests. Rather than immediately activating a defensive state, ISR primes for faster and stronger defenses by hypersensitizing the plant to potential threats \[[@CR64]\]. A variety of *Paenibacillus* species seem to elicit ISR against pathogenic bacteria \[[@CR49], [@CR65]\], fungi \[[@CR50], [@CR66]--[@CR68]\], nematodes \[[@CR69]\], and viruses \[[@CR70]\].

The ISR pathway begins when the plant recognizes elicitors from the beneficial microorganism, such as structural proteins, enzymes, reactive oxygen species, or volatile organic compounds \[[@CR64], [@CR71]\]. ISR can lead to increased systemic levels of the plant hormone salicyclic acid (SA-dependent response), or to an SA-independent response. The latter can include increased transcription of genes that are regulated by the plant hormones jasmonic acid, or enhanced expression of genes that are responsive to jasmonic acid or ethylene, which are then induced upon attack. In addition, SA-independent ISR can prime for physical responses such as enhanced callose deposition at sites of pathogen entry, which is regulated by abscisic acid and creates a structural barrier against further attack. While there are exceptions, SA-dependent ISR typically induces mechanisms against biotrophic pathogens (those requiring that the host cells remain alive), while the jasmonic acid/ethylene pathway protects against cell death-provoking necrotrophs and against insect herbiviores \[[@CR64]\].

Among *Paenibacillus* species, ISR has been demonstrated for *P. polymyxa*, *P. alvei*, *P. elgii*, and *P. lentimorbus*. For example, *P. polymyxa* strain KNUC265 was shown to protect against the bacterial pathogens *Xanthomonas axonopodis* and *Erwinia carotovora* in pepper and tobacco, respectively, using bacterial volatiles and diffusible metabolites as elicitors \[[@CR49]\]. *P. polymyxa* E681 was shown to use volatile organic compound elicitors to protect *Arabidopsis thaliana* against the bacterium *Pseudomonas syringae* via primed transcription of salicylic acid, jasmonic acid, and ethylene signaling genes \[[@CR65]\]. Consistent with the typical roles of SA-dependent and jasmonic acid/ethylene pathways, *Pseudomonas syringae* is described as a hemibiotrophic pathogen, with both biotrophic and necrotrophic stages \[[@CR72]\]. Similarly, *Arabidopsis thaliana* is primed by *P. alvei* K165 against a hemibiotrophic fungus \[[@CR54]\], *Verticillium dahlia*, by both salicylate and jasmonate-dependent pathways \[[@CR68]\]; while cucumber is primed by *P. elgii* MM-B22 against the hemibiotrohic fungus \[[@CR54]\] *Colletotrichum orbiculare*, responding to attack with defense-related enzymes and H~2~O~2~-induced cell death \[[@CR67]\]. Priming of tobacco by *P. lentimorbus* B-30488 also results in accumulation of defense-related enzymes in response to cucumber mosaic virus infection \[[@CR70]\].

Insecticides {#Sec9}
------------

*Paenibacillus* species have been shown to kill larvae of pest insects including beetles \[[@CR73]\] and lepidopterans \[[@CR74]\]. *Paenibacillus popilliae*, which infects larvae of the Japanese beetle, *Popillia japonica*, was the first microbial control agent registered in the US for use against an insect. However, its use was never widespread due in part to the inability of this particular species to be cultured in synthetic media \[[@CR75]\]. Nonetheless, research continues into the potential of *Paenibacillus* species for insect pest control, with the effective proteins including chitinase and crystal protein (Cry).

Chitinase enzymes produced by *Paenibacillus* hydrolyse chitin, which is a structural polysaccharide of insect exoskeletons and gut linings, leading to low feeding rates and death of infected insects. Both *Paenibacillus* sp. D1, from a seafood industry effluent treatment plant, and its isolated chitinase have been shown to cause concentration-dependent mortality of cotton bollworm (*Helicoverpa armigera*) when coated onto leaves fed to the larvae \[[@CR76]\]. *Paenibacillus* sp. D1 and its chitinase are tolerant to common insecticidal chemicals, and the chitinase itself is also highly stable in the field at 40 °C \[[@CR60]\], indicating the potential of the organism or its enzyme to be used as insecticide in the field.

Cry proteins are best known for conferring insecticidal activity to the bacterium *Bacillus thuringiensis* and to genetically modified crops. Following ingestion, these proteins form pores in the insect midgut epithelial cells, resulting in cell lysis and death \[[@CR77]\]. Cry homologs from *Paenibacillus lentimorbus* strain Semadara, which was isolated from larvae of the beetle *Blitopertha orientalis*, have been shown to cause mortality of beetle larvae \[[@CR78]\]. Genes encoding Cry have also been found in *P. popilliae* \[[@CR79]\] and *Paenibacillus* spp. Kh3 \[[@CR80]\]. In addition, *P. polymyxa* NMO10 has been genetically engineered with Cry1C from *B. thuringiensis* in order to combine the insecticidal activity of Cry and the growth promotion properties of *P. polymyxa*. The modified strain demonstrated greater toxicity than *B. thuringiensis* against lepidopteran insects \[[@CR81], [@CR82]\].

While insecticidal activities of *Paenibacillus* species may contribute to insect pest control, it is important to note that interactions between species in the field can be complex and non-target effects of biocontrol agents needs to be considered. For example, large populations of *Paenibacillus* species, or *P. polymyxa* alone, near the root system can actually increase the susceptibility of plants to aphids, possibly via increased levels of the plant growth promoting hormone IAA \[[@CR83]\]. Furthermore, while various *Paenibacillus* species suppress parasitic nematodes, most notably the root-knot nematode *Meloidogyne incognita*, *P. nematophilus* has been found to impede dispersal of the beneficial nematode *Heterorhabditis megidis* and reduce its infectivity of moth larvae \[[@CR63]\].

Antimicrobials {#Sec10}
--------------

Many *Paenibacillus* species compete with other microorganisms through the production of a wide range of antimicrobial compounds. In one study, 25 of 55 isolates from water and soil exhibited a broad inhibition spectrum against tested bacteria and pathogenic fungi Lorentz RH, Ártico S, Da Silveira AB, Einsfeld A and Corção G \[[@CR84]\], suggesting that a good proportion of *Paenibacillus* species are likely to produce antimicrobials. Yet diversity exists even within the same species: of 25 strains of *P. polymyxa*, 15 were strongly inhibitory to the oomycete pathogen *Phytophthora capsici*, while 10 showed weak or no antimicrobial effect \[[@CR85]\]; and genome sequencing confirms the diversity of antimicrobial-encoding gene clusters among *P. polymyxa* strains \[[@CR26], [@CR27]\].

Various *Paenibacillus* strains, or their isolated antimicrobial compounds, could therefore be useful in controlling phytopathogenic microorganisms, leading to lower usage of chemical biocides which can have negative environmental effects. Soilborne fungal pathogens, in particular, require high doses of chemical fungicides for control due to their wide host spectra and persistence in soil \[[@CR53]\]. The antimicrobial activities of *Paenibacillus* may also be useful for post-harvest control of food-borne bacteria, such as *Salmonella*, that are pathogenic to humans \[[@CR86]\].

The antimicrobials produced by *Paenibacillus* include peptides, enzymes, and volatile organic compounds (VOCs). While antimicrobial peptides are extremely significant for biocontrol in agriculture, the purified or synthesized peptides also have realised and potential uses in medicine and food processing, and are therefore discussed further in a separate section (see "[Antimicrobial peptides](#Sec11){ref-type="sec"}" section).

Hydrolytic enzymes of *Paenibacillus* can attack the cell walls of fungal and oomycete competitors. Cell walls of filamentous fungi contain a large fraction of β-1,3-glucan and chitin, while those of oomycetes consist primarily of β-1,3-glucan, β-1,6-glucan and cellulose; and both contain up to 11% protein. Various species of soil-dwelling *Paenibacillus* have been found to produce glucanses, chitinases, cellulases, and proteases that are implicated in the destruction of eukaryote cell walls. For example, crude enzyme extract from *P. ehimensis* KWN38 was shown to deform hyphal morphology and prevent growth of the basidiomycete fungus *Rhizoctonia solani*, the ascomycete fungus *Fusarium oxysporum*, and the oomycete *Phytophthora capsici*, all of which are phytopathogens \[[@CR53]\]. Glucanases and chitinases from strains including *P. ehimensis* IB-X, *P. ehimensis* MA2012, and *P. polymyxa* A21 have been shown to damage cell wall structures and/or inhibit *R. solani*, the oomycete *Pythium aphanidermatum*, and the ascomycetes *Alternaria alternata*, *Botrytis cinerea*, *Colletotrichum gloeosporioides*, and *Drechlera sorokiniana* \[[@CR87]--[@CR90]\]. A chitinase from *Paenibacillus* sp. D1 also exhibited high stability in presence of commonly used fungicides, suggesting the potential of some hydrolytic enzymes as additives to chemical fungicides \[[@CR91]\].

VOCs can enhance interactions between soil-dwelling microorganisms, as these compounds diffuse through air-filled pores in the soil to reach physically separated organisms \[[@CR92]\]. A large number of VOCs are produced by *Paenibacillus* species \[[@CR93], [@CR94]\] as well as other microorganisms \[[@CR92]\]. For example, *P. polymyxa* WR-2 was found to produce 42 VOCs, over 30 of which had some degree of antifungal activity against *F. oxysporum*, including 13 that completely inhibited its growth. The compounds included benzenes, aldehydes, keytones, and alcohols, although some were produced in low quantities; with benzothiazole, benzaldehyde, undecanal, dodecanal, hexadecanal, 2-tridecanone and phenol being the main antifungal compounds \[[@CR94]\]. Antimicrobial VOCs have application for biocontrol of agricultural pathogens, post-harvest diseases (particularly of fruit), and building molds \[[@CR92]\].

In addition to the antimicrobials described above, a non-volatile organic compound, methyl 2,3-dihydroxybenzoate, from *P. elgii* HOA73 was found inhibited growth of *B. cinerea*, *F. oxysporum*. *P. capsici*, and *R. solani* \[[@CR95]\].

Antimicrobial peptides {#Sec11}
======================

Further to "[Antimicrobials](#Sec10){ref-type="sec"}" section, *Paenibacillus* produces antimicrobial peptides with realised or potential applications in agriculture, medicine, and food processing. These peptides are of two types: ribosomally-synthesized bacteriocins, and non-ribosomally synthesized peptides, where amino acids are incorporated independently of messenger RNA.

Bacteriocins {#Sec12}
------------

Bacteriocins are ribosomally synthesized, proteinaceous toxins that inhibit the growth of bacteria that are related to the producer. *Paenibacillus* species are known to produce at least two of the three classes of bacteriocins, being lantibiotics and pediocins.

Lantibiotics, also known as Class I bacteriocins, contain the non-coded amino acid lanthionine \[[@CR96]\]. They are typically active against Gram-positive bacteria, as the outer membrane of Gram-negative bacteria presents a natural barrier. However, some gram negatives can be affected at high concentrations \[[@CR97]\].

Lantibiotics are usually expressed at the late exponential phase or early stationary phase of bacterial growth, and are encoded in a cluster along with genes required for their extensive post-translational modifications \[[@CR96]\]. In *P. polymyxa* OSY-DF, for example, the paenibacillin prepropeptide is encoded in a cluster that also contains putative genes for lantibiotic dehydratase, lantibiotic cyclase, acetylase, peptidase, and an ATP-binding cassette (ABC) transporter that may function for export to the extracellular space \[[@CR96]\]. Other lantibiotics include paenicidin A produced by *P. polymyxa* NRRL B-30509 \[[@CR98]\] and penisin produced by *Paenibacillus* sp. strain A3 \[[@CR99]\].

Lantibiotics in *Paenibacillus* are fairly recent discoveries, with Paenibacillin first reported in 2007 \[[@CR100]\]. However, the lantibiotic Nisin, produced by *Lactococcus lactis*, has been in commercial use since the 1950s, both as a food preservative and in veterinary medicine. Lantibiotics have low toxicity toward mammals and are poorly immunogenic, meaning there is little risk of adverse effects \[[@CR97]\]. Paenibacillin has the advantages of pH and heat stability, as well as activity against a broad range of foodborne pathogens and spoilage bacteria, making it an attractive candidate for food preservation \[[@CR101]\].

Compared to these lantibiotics, less research has been done on *Paenibacillus*-produced pediocins, also known as Class II bacteriocins. Pediocins are nonmodified, linear peptides, and include SRCAM 37 and SRCAM602 produced by *P. polymyxa* \[[@CR101]\].

Nonribosomal lipopeptides {#Sec13}
-------------------------

In contrast to bacteriocins, many antimicrobial peptides produced by *Paenibacillus* are synthesized nonribosomally, independently of RNA. Here, the amino acid residues are pieced together by nonribosomal peptide synthetases (NRPSs), which are multienzyme complexes that can incorporate a mixture of [d]{.smallcaps} and [l]{.smallcaps} amino acids. Each module of an NRSP incorporates one or more specific amino acids into the peptide chain. Resulting peptides show great diversity in sequence and structure, and an enhanced resistance to proteolytic enzymes. The nonribosomal lipopeptides act primarily by disrupting membranes of the target cells, and because it is difficult for target organism to reorganize their membranes, development of resistance is usually slow \[[@CR102]\].

Nonribosomal lipopeptides can be categorized as linear cationic, cyclic cationic, or cyclic noncationic. Although they are the most amenable to chemical synthesis, limited research has been conducted on linear cationic nonribosomal lipopeptides. In *Paenibacillus*, these include saltavalin, jolipeptin, and tridecaptins \[[@CR102]\].

### Cyclic cationic lipopeptides {#Sec14}

The most thoroughly researched cyclic cationic lipopeptides from *Paenibacillus* are the polymyxins, first isolated from *P. polymyxa* in 1947, although they are also produced by strains of *P. alvei* \[[@CR103]\], *P. kobensis* \[[@CR55]\], and possibly other species. These are a family of peptides each consisting of a polycationic diaminobutyryl-containing heptapeptide ring and tripeptide side chain with a fatty acid derivative at the N-terminus \[[@CR104]\]. Members of the family include polymyxin A, B, C, D, E (also called colistin), M (also called mattacin), P, S, and T \[[@CR103]--[@CR106]\]. These polymyxins differ from each other in amino acid composition at residues 3, 6, and 7, including D vs L stereochemistry of amino acids. Subgroups (e.g. polymyxin E~1~ and E~2~) differ in the lipid moiety and/or the amino acid at residue 7 \[[@CR103]\]. Amino acid diversity is thought to arise from combinatorial chemistry, due to mixing and matching of alleles of the NRPS modular domains \[[@CR104]\]. Polymyxin gene clusters found to date each encode three multi-modular NRPSs and two ABC transporters \[[@CR103], [@CR107]\].

Polymyxins bind to the lipid A component of lipopolysaccharide on the outer membrane of gram-negative bacteria to disrupt the outer membrane, then permeabilize and disrupt the inner membrane. Most cases of resistance occur in strains that have modified lipid A to reduce its net negative charge, thereby reducing affinity for polymyxin \[[@CR102]\].

Polymyxins B and E are produced industrially from *P. polymyxa* strains \[[@CR103]\]. They are used in ointments, such as the antibiotic creams Neosporin and Polysporin (both contain polymyxin B), for the treatment and prevention of topical skin infections; and as last-resort treatments for multidrug resistant internal infections \[[@CR108]\]. While polymyxins were used extensively from the 1940s until the 1970s to treat gram-negative bacterial infections, their clinical uses are currently limited primarily because of toxicity to the human central nervous system and kidneys. While this toxicity may be less severe than previously reported \[[@CR102]\], synthetic production with modifications can create new polymyxins with improved pharmacokinetic properties as well as activity against resistant bacteria \[[@CR109]\].

Other cyclic cationic lipopeptides produced by *Paenibacillus* include octapeptins (e.g. battacin), paenibacterin, polypeptins (e.g. pelgipeptin), and gavaserin. Octapeptins have the structure of truncated polymyxins, but are active against both Gram-negative and Gram-positive bacteria, and are less toxic \[[@CR102]\]. Paenibacterin is a cyclic 13-residue amino acid produced by *P. thiaminolyticus* OSY-SE, with activity against Gram negative and positive bacteria \[[@CR59]\].

### Cyclic noncationic lipopeptides {#Sec15}

The cyclic noncationic lipopeptides found so far in *Paenibacillus* are fusaricidins, first reported in *P. polymyxa* KT-8 in 1996 \[[@CR110]\]. These are hexapeptide rings that contain one or more ester bonds in addition to the amide bonds (depsipeptides), with an attached guanidinylated ß-hydroxy fatty acid \[[@CR104], [@CR111]\]. A single operon produces a variety of fusaricidins, differing in their incorporation of amino acids at three of the six positions in the peptide ring. The diversity here is due to relaxed substrate specificity of the NRPS \[[@CR112]\], in contrast to the modular mixing of polymyxin synthases. Fusaricidins are active against fungi, including many important phytopathogens, and a variety of gram-positive bacteria. Both naturally occurring structures and synthetic modifications can be chemically synthesized, creating improved stability and decreased nonspecific cytotoxicity toward human cells \[[@CR111]\].

Other medical applications {#Sec16}
==========================

In addition to a diverse array of antimicrobials, *Paenibacillus* produce other compounds that may be useful in medicine and dentistry. Their exo-polysaccharides (EPS) have antioxidant and anti-tumour properties, while mutanase enzymes may help to reduce tooth decay.

Microbial EPSs are water-soluble polymers that attach to the cell surfaces or are released into the medium. Strains of *Paenibacillus* produce EPSs with varying characteristics that may be medically useful. For example, those from *P. polymyxa* SQR-21 and *P. polymyxa* EJS-3 have superoxide scavenging activity and inhibit lipid peroxide \[[@CR113], [@CR114]\]. Some of these EPSs have been found to reduce oxidative stress in the livers of mice and inhibit in vitro growth of gastric cancer cells \[[@CR114]\].

Mutanases, also called (1→3)-α-glucanases, from *Paenibacillus* may be useful to help prevent tooth decay. These enzymes break down branched (1→3),(1→6)-α-[D]{.smallcaps}-glucans (mutans) which are produced by commensal streptococci and which form a major component of dental biofilm (plaque) that can harbor cariogenic bacteria. In contrast to the other polysaccharides and proteins in the biofilm, mutans are resistant to enzymes produced by oral microorganisms, and are substantially rigid and water-insoluble, thus are not dissolved and washed away by oral fluid \[[@CR115]\].

Mutanases are produced by fungi and bacteria, including *P. curdlanolyticus*, *P. glycanilyticus*, and *P. humicus*. However, these enzymes are not widespread in nature and are not produced by oral microorganisms, with producing bacteria usually isolated from soil. The bacterial enzymes are typically endo-(1→3)-α-glucanases, which cleave internal (1→3)-α-linkages at random sites along the glucan chain. These mutanases tend to be more stable than their fungal counterparts, and are active at a higher pH that is more consistent with the oral environment \[[@CR115]\].

A marketed oral rinse, Biotene PBF (Laclede Professional Products), contained mutanase among other components, but the product's effectiveness was not proven, which may be due to a variety of reasons. In many cases, mutanase production requires inducing (1→3)-α-glucans, which have been difficult to make in quantities large enough to support products with high enzyme concentrations. However, (1→3)-α-glucan components of fungal cell walls have more recently been shown to induce mutanase expression in *Paenibacillus* and other organisms \[[@CR115]\].

Process manufacturing {#Sec17}
=====================

*Paenibacillus* strains produce a variety of enzymes with potential applications in industrial process manufacturing for detergents, food, textiles, paper, and biofuel; including amylases, cellulases, hemicellulases, lipases, pectinases, and lignin-modifying enzymes (Additional file [3](#MOESM3){ref-type="media"}). Although enzymes sourced from *Paenibacillus* are not presently used in these processes, the search is ongoing for enzymes that are highly active under industrially-relevant conditions, have improved stability, or can be produced at a lower cost than currently available alternatives.

The laundry and dish detergents industry is the primary consumer of industrial enzymes. Proteases, lipases, amylases, and sometimes hemicellulases, are used to break down food and other organic residues, such as blood and grass stains. Cellulases are also used in laundry detergents to restore the smooth look and feel cotton-based fabric, by removing small balls of fibers that form on the cloth during wearing and washing. The other major industry to use enzymes is food, feed, and beverages. Here, amylases convert starches into sugar sweeteners such as high-fructose corn syrup, and create precursors for brewing alcoholic beverages. Cellulases and pectinases are used to extract and clarify juices, and, along with hemicellulases, to improve the nutritional quality of animal feeds. In the textile industry, pectinases, proteases, and lipases remove impurities from cotton and enhance wettability for dyeing and finishing; amylases remove coating agents from yard after it is woven (desizing); and cellulases can produced a "stonewashed" denim finish. For paper products and cellulosic biofuel, microbial enzymes can help remove lignin that causes paper to yellow and reduces the availability of fibers for saccharification and fermentation to biofuels. After lignin removal, cellulases and hemicellulases can alter fiber properties for paper manufacturing, or hydrolyze fibers for bioethanol or biobutanol production. For an alternative biofuel, lipases can serve as transesterification catalysts for biodiesel production \[[@CR116]\].

Cold-active enzymes are desirable for laundry detergents, as washing with cold water reduces energy consumption and fabric wear. Fittingly, cold-active protease, amylase, xylanase, and cellulase are efficiently produced by *P. terrae* \[[@CR117]\]. For most other applications, thermostability and activity under harsh conditions are desired. Accordingly, a cellulase from *P. chitinolyticus* CKS1 has optimal activity at 80 °C and pH 4.8 \[[@CR118]\]; while another from *P. tarimensis* retains high activity from pH 3.0 to 10.5, from 9 mM to 5 M NaCl, at 80 °C in high salt, and in the presence of organic solvents, EDTA, and heavy metals \[[@CR119]\].

Bioremediation {#Sec18}
==============

A variety of industries including petroleum, textiles, pulp and paper, and other chemical industries can unintentionally or intentionally release large amounts of organic pollutant compounds and heavy metals. *Paenibacillus* species may be utilized in the removal or degradation of these environmental pollutants, through bioflocculation or enzymatic activities.

Often used for wastewater treatment, flocculation is a process that removes suspended particles from liquids, frequently through the addition of chemicals (flocculants) that promote aggregation. Many microorganism including bacteria, fungi, and algae can produce biological flocculants consisting of polysaccharides, proteins, or other macromolecules. Strains of *P. jamilae*, *P. macerans*, *P. polymyxa*, and *P. validus* have been shown to promote bioflocculation of heavy metal ions or acid dyes; and *P. elgii* B69 produces an exopolysaccharide (EPS) bioflocculant that can remove multiple pollutants including heavy metal ions, dyes, and kaolin clay over a wide pH range \[[@CR120]\]. *Paenibacillus* could therefore be used to help remove contaminants from a variety of wastewaters.

To degrade contaminants, either in wastewaters or at sites of environmental spills, *Paenibacillus* can produce various enzymes that metabolize aliphatic and aromatic organic pollutants, including oxygenases, dehydrogenases, and ligninolytic enzymes \[[@CR121], [@CR122]\]. The textiles industry produces multiple chemicals that can pollute natural waters and soils, most notably dyes that are released due to inadequate wastewater treatment \[[@CR123]\]. Strains of *Paenibacillus*, either on their own or in concert with other bacteria, are able to degrade many textile dyes \[[@CR124]--[@CR126]\] and polyvinyl alcohol (PVA), which is used as a coating for textile and paper fibers \[[@CR127]\]. Other hazardous effluents produced by pulp and paper mills can be decontaminated by *Paenibacillus* \[[@CR128]\].

*Paenibacillus* strains can also degrade pollutants derived from extracting, refining, and transporting petroleum and coal tar, including crude oil \[[@CR129]\], diesel fuel \[[@CR130]\], bitumen \[[@CR131]\], disulfide oils \[[@CR132]\]; and the polycyclic aromatic hydrocarbons (PAHs) naphthalene \[[@CR133]\], phenanthrene \[[@CR134]\], and pyrene \[[@CR135]\]. Strains can also degrade the chemical gasoline additives ethyl tert-butyl ether \[[@CR136]\] and benzene \[[@CR134]\], the latter of which is also used in the production of chemicals and plastics, including nylon.

Pathogenicity {#Sec19}
=============

Some *Paenibacillus* species are known to infect various organisms, including honeybees and the parasite vector *Biomphalaria glabrata*, and occasionally present as opportunistic infections in humans.

Honeybee disease {#Sec20}
----------------

The most studied disease associated with *Paenibacillus* is American Foulbrood (AFB), caused by *P. larvae*. AFB afflicts honeybee (*Apis* species) colonies globally, and is the most destructive brood disease \[[@CR137]\].

Although tylosin, lincomycin, and oxytetracycline \[[@CR138]\] are effective antibiotics against *P. larvae*, antibiotics are poorly metabolized by honeybees, and their residues or those of their metabolites can be stable in honey for over a year. Elimination of the residues can only occur when the honeybees consume all of it or when the beekeeper removes the contaminated food \[[@CR139]\]. Residual antibiotics or their metabolites cause issues when the honey is meant for human consumption, as they can trigger allergic reactions, harm healthy microbiota, and confer resistance to pathogenic bacterial strains. Additionally, *P. larvae* resistance to antibiotics such as oxytetracycline has become increasingly more common in recent years \[[@CR140]\]. The current most typical solution to deal with an AFB affliction is to burn the entire hive.

AFB is caused by four strains of *P. larvae*, named ERIC I-IV based on the identities of their enterobacterial repetitive intergenic consensus (ERIC) sequences. ERIC I and II are the types typically isolated from afflicted hives, as ERIC III and IV are less virulent \[[@CR38], [@CR140]--[@CR145]\]. While ERIC II is the most virulent strain, ERIC I is more prevalent globally, likely because it can infect all honeybee subspecies, whereas ERIC II is restricted to certain subspecies \[[@CR137]\].

As the most virulent strain, *P. larvae* ERIC II has a larval LT~100~ (time it takes the entire colony's larvae to die) of just 7 days \[[@CR145]\]. This strain produces a unique functional S-layer protein which facilitates attachment of the bacteria to the peritrophic matrix that lines the honeybee's midgut epithelium \[[@CR146]\]. By contrast, *P. larvae* ERIC I has a larval LT~100~ of 12 days \[[@CR145]\] and produces a toxin known as the C3larvin toxin which may contribute to its pathogenicity. Although its target substrate has not been determined, this toxin acts as an ADP-ribosyltransferase and is lethal when expressed in yeast in vitro \[[@CR147]\].

Both ERIC I and ERIC II have an invasive spore stage and a non-invasive vegetative stage. Initial ingestion of spore-contaminated food by the larvae marks the beginning of the non-invasive phase. The spores travel to the midgut lumen and germinate, after which the bacteria proliferate rapidly. Honeybee larvae are most susceptible to infection within the first 36 h after hatching, and only a few spores are needed to initiate infection. After this window, the peritrophic matrix is too thick for the bacteria to penetrate and colonization is never achieved. Both strains use chitinases to degrade the peritrophic matrix for both nourishment and access to the midgut epithelium \[[@CR146]\].

The S-layer protein expressed by ERIC II facilitates initial association of the bacteria to the peritrophic matrix, and ERIC I may have a similar protein. If the bacteria are successful in degrading the peritrophic matrix, they eventually penetrate into the midgut epithelium and the haemocoel using chitinases and proteases, marking the invasive phase. The host larvae dies soon after from bacteremia \[[@CR145]\]. Adult honeybees are not susceptible to infection, and so in the process of cleaning contaminated cells they tend to transfer spores all over the hive. In this way the infection spreads horizontally. The infection can also spread vertically when a contaminated mother colony infects its daughter swarm upon establishment of a new colony. The horizontal mode of transmission is much more virulent and can occur both within and between hives \[[@CR148]\]. Further attributing to the pathogenicity of *P. larvae* are the paenilimicins and paenilarvins that it produces. Paenilimicins are antimicrobials that fight ecological niche competitors and are not directly involved in killing the bee larvae, while paenilarvins are antifungal compounds which also negatively affect bee larvae \[[@CR142], [@CR143]\]. As such, paenilicmins and paenilarvins promote the survival and colonization of *P. larvae* within honeybee larvae, while paenilarvins have the added disadvantage of directly impacting the health of the bee. ERIC II produces four paenilimicins: A1, A2, B1, and B2. In addition, paenilarvins A and B are produced as a secondary metabolite during the infection of *P. larvae* \[[@CR143]\]. Other nonribosomal peptides and peptide-polyketide hybrids are *P. larvae* secondary metabolites which are expected to have additional roles in the bacteria's pathogenicity \[[@CR149]\].

Several naturally isolated substances and compounds have shown potential in *P. larvae* inhibition. Both monofloral and polyfloral honey demonstrate in vitro activity against *P. larvae* strains, and this is likely due in part to the high concentration of sugar causing extreme osmotic stress for the bacteria. In addition, nectar contains several antimicrobial secondary plant metabolites whose presence can be detected in processed honey. Because these secondary metabolites are species-specific in their antagonism, polyfloral honey tends to confer more resistance than monofloral honey, as it contains the metabolites from several plant nectars \[[@CR140]\]. Propolis, a substance derived from plant resins, is used by bees in the construction of their hives and also shows inhibitory activity against *P. larvae* \[[@CR150], [@CR151]\]. It was also discovered that multiple Hypericum extracts have the potential to inhibit *P. larvae* in vitro, including hyperforin, uliginosin A and B, 7-epiclusianone, albasidin AA, and drummondin E \[[@CR144]\]. Other compounds demonstrating potential to control *P. larvae* infections include *Azadirachta indica, Vitex trifolia*, *Calendula officinalis*, and *Nasturtium officinale* extracts \[[@CR152], [@CR153]\], a collection of essential oils \[[@CR154]\], and frozen as well as freeze-dried sunflower bee pollen \[[@CR155]\]. Certain other bacterial species demonstrate antagonistic activity to *P. larvae*, including *Bacillus polymachus* which shows potential as a biocontrol agent \[[@CR156]\]. Multiple *Enterococcus* species have demonstrated antagonistic activity to *P. larvae*, and this is believed to be due to the bacteriocin genes found in their genomes \[[@CR157]\]. A novel *P. larvae* phage phiIBB-Pl23 produces an endolysin which effectively kills *P. larvae* while at the same time remains nontoxic to bees \[[@CR158]\].

Different species of honeybees glycosylate their royal jelly proteins in distinct patterns, which seems to have an influence on their vulnerability to *P. larvae* infections. *Apis mellifera* lingustica's royal jelly proteins display higher antihypertension activity than those produced by *Apis cerana* cerana and is active at lower levels. Interestingly, this difference in activity grants *Apis mellifera* lingustica optimized molecular functioning and enhanced immune activity, and so the strain is more resistant to *P. larvae* than is *Apis cerana* cerana in that larval exposure to the spores results in infection less frequently \[[@CR159]\]. Although the strain tested was ERIC I, this may help to explain the specificity observed in *P. larvae* ERIC II infections. These findings have implications when exploring potential techniques to control AFB, as well as in discovering novel techniques for controlling human hypertensive disease.

Another species of bacteria believed to put the honeybee at risk is *P. apiarius* \[[@CR160]\]. Although not the primary cause of disease, *P. alvei* acts as a secondary infector in cases of European Foulbrood, along with other species of pathogenic bacteria including *Enterococcus faecalis*, *Brevibacillus laterosporus*, *Bacillus pumilus*, *Achromobacter euridice* \[[@CR140]\], and *P. dendritiformis* \[[@CR161]\].

Snail disease {#Sec21}
-------------

*P. glabratella* was originally isolated from visible white nodules on snails in a population with high mortality. This species causes significant mortality in infected *Biomphalaria glabrata* snail populations, and is highly contagious among members of the population. Moreover, infected snails produce infected eggs causing decreased levels of hatching. These findings hold promise for *P. glabratella* as a potential biocontrol agent against the tropical parasitic disease Schistosomiasis which commonly uses these snails as vectors \[[@CR162]\]. This has implications in developing countries where parasites are a significant cause of death. Schistosomiasis ranks second globally among parasitic diseases of public health and socio-economic importance and is endemic in Africa \[[@CR163]\].

Opportunistic infections of humans {#Sec22}
----------------------------------

Several *Paenibacillus* species have been isolated from humans globally (Additional file [1](#MOESM1){ref-type="media"}). Although the majority of these colonisations are not harmful to their host, some have demonstrated pathogenicity to humans. In almost every case, *Paenibacillus* infections are opportunistic and tend to infect immunocompromised people. Diseases or syndromes associated with *Paenibacillus* infection include chronic kidney disease \[[@CR164]\], sickle cell disease \[[@CR165]\], premature birth \[[@CR166]\], Whipple's disease \[[@CR167]\], hydrocephalus \[[@CR168]\], skin cancer, chronic interstitial nephropathy, and acute lymphoblastic leukemia \[[@CR169]\]. In many of these cases it is unclear whether the relationship between the infection and the disease was correlated or causal, but it is likely that *Paenibacillus* was simply occupying suitable niches opportunistically. Many human-recovered *Paenibacillus* isolates come from elderly patients whose immune systems are generally weak.

A significant risk factor to *Paenibacillus* infection is the use of intravenous drugs. Intravenous drug use grants bacteria and other contaminants entry into the blood stream which would normally be unexposed to these pathogens. In one case, *P. amylolyticus* coinfection with *Lysinibacillus fusiformis* caused bacteremia leading to sepsis in an immunocompromised patient known to use intravenous heroin \[[@CR170]\]. Additionally, several cases of *P. larvae* bacteremia have been caused by the use of intravenous methadone prepared with honey from hives infected with *P. larvae.* Some pharmacies are known to prepare methadone using a viscous substance such as honey to prevent patients from misusing it through injection. If residual *P. larvae* spores in the honey happen to be injected through intentional misuse, they can germinate under proper conditions and cause infection \[[@CR171]\].

*Paenibacillus* isolated from humans have demonstrated a variety of strain-dependent drug resistances including resistances to norfloxacin, clindamycin, ampicillin, and ticarcillinclavulanic acid. Successful drug treatments have included cefotaxime, ceftrixone, and a treatment involving amikacin and zosyn followed by po Levofloxacin \[[@CR164], [@CR165], [@CR172]\].

Dairy spoilage {#Sec23}
==============

Another well-known negative aspect of *Paenibacillus* is its role in the spoilage of milk and other dairy products. *Paenibacillus* is among the most important bacterial genera that produce spoilage enzymes in the dairy industry, along with *Bacillus* and *Viridibacillus*. Endospores of these genera are able to survive extreme conditions including high heat, pressure, biocides, and UV irradiation, allowing them to withstand pasteurization and persist in industrial equipment. Small numbers of *Paenibacillus* spores can therefore be found in both raw and pasteurized milk \[[@CR173]\].

Many *Paenibacillus* strains also grow well at refrigeration temperature. *Paenibacillus* represents more than 95% of bacteria in raw milk after 10 days of refrigerated shelf life \[[@CR173]\], while spoilage of pasteurized milk due to *Paenibacillus* is delayed by the germination process of spores and usually occurs after 17--21 days \[[@CR174]\]. Strains that are able to grow at low temperature (6 °C) share numerous genetic features including genes that encode peptidases with cold-adapted features and cold-adaptation related proteins \[[@CR175]\].

While *Paenibacillus* enzymes can be beneficial to other industries (see "[Process manufacturing](#Sec17){ref-type="sec"}" section), their proteases, lipases, and phospholipases negatively impact the texture of dairy products, such as curdling caused by proteases, as well as the flavour \[[@CR173]\]. However, not all dairy-isolated strains produce these activities \[[@CR174]\]. *Paenibacillus* species isolated from dairy products include *P. amylolyticus*, *P. lactis*, *P. lentimorbus*, *P. lucanolyticus*, *P. odorifer*, *P. peoriae*, and *P. stellifer* \[[@CR173], [@CR174], [@CR176]\].

Conclusions {#Sec24}
===========

*Paenibacillus* was separated from *Bacillus* in 1993, but is a paraphyletic genus that is likely to undergo further subdivision in the future. This diverse genus has relevance in many areas, spurring numerous genome sequencing projects and patents. Many species are well-known plant-growth promoters, with various strains capable of promoting plant nutrient uptake, controlling phytopathogens, and producing phytohormones. The usefulness of inoculating *Paenibacillus* in the field can be restricted by various environmental conditions, but further research into the establishment and performance of these species within complex soil ecosystems may allow for their widespread use as biofertilizer. In addition to agricultural applications, *Paenibacillus* produces a diversity of antimicrobials, enzymes, and exopolysaccharides with relevance in medicine, process manufacturing, and bioremediation, some of which have already been commercialized. However, the genus is not purely beneficial, with some species causing food spoilage, honeybee disease, or opportunistic infections in humans. Still, the future can expect more discoveries and optimizations that will allow *Paenibacillus* to contribute positively to health and sustainable processes.

Additional files {#Sec25}
================

**Additional file 1.** All discovered *Paenibacillus* species along with their countries, environments, and years of isolation. **Additional file 2.** List of *Paenibacillus* genome sequencing projects and their progress. **Additional file 3.** Secreted compounds and significant enzymes produced by members of the genus *Paenibacillus.*

ABC

:   ATP-binding cassette

AFB

:   American Foulbrood

Anf

:   iron-dependent nitrogenase

Cry

:   crystal protein

DHB

:   dihydroxybenzoate

EPS

:   exo-polysaccharide

ERIC

:   enterobacterial repetitive intergenic consensus

IAA

:   indole-3-acetic acid

IpdC

:   indolepyruvate decarboxylase

ISR

:   induced systemic resistance

LT~100~

:   time required to kill 100% of subjects

Nif

:   molybdenum-dependent nitrogenase

NRSP

:   nonribosomal peptide synthetase

PAH

:   polycyclic aromatic hydrocarbon

PVA

:   polyvinyl alcohol

Vnf

:   vanadium- and iron-dependent nitrogenase

VOC

:   volatile organic compound
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